AJ Lanigan: Yes. Actually, Pharma businesses are generating huge revenue with therapies like Keytruda and Opdivo that deal with PD-1 and PD-L1. Below’s the super cool part: imagine checkpoints as site visitors alerts. You don’t want an immune program that’s managing wild similar to a freight teach above a cliff. waiting for link from Social Bookmarking